Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342
Clinical trial NCT01669096 · COMPLETED
Trial details
- NCT number
- NCT01669096
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-21
- Primary completion
- 2012-12-06
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.